Medifast, Inc. (NYSE:MED) Q4 2021 Earnings Conference Call February 23, 2022 4:30 PM ET Company Participants Reed Anderson ??? Investor Relations-ICR, Inc. Dan Chard ??? Chairman and Chief Executive Officer Jim Maloney ??? Chief Financial Officer Conference Call Participants Steph Wissink ??? Jefferies Linda Bolton Weiser ??? D.A. Davidson Doug Lane ??? Lane Research Operator Good day, and welcome to the Medifast Fiscal Fourth Quarter and Full Year 2021 Earnings Conference Call. All participants will be in ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from____________to____________. Commission file number: 001-31573 Medifast, Inc. (Exact name of registrant as specified in its charter) | Delaware | 13-3714405 | | ...

MEDIFAST. 1 OPTAVIA INVESTOR PRESENTATIONS Q4 2021 Safe Harbor Statement Certain information included in this presentation may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend," "anticipate," "expects" or other s ...

Medifast, Inc. (NYSE:MED) Q3 2021 Earnings Conference Call November 4, 2021 4:30 PM ET Company Participants Reed Anderson - Investor Relations Dan Chard - Chairman and Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Chris Neamonitis - Jefferies Operator Good day and welcome to the Medifast Third Quarter 2021 Earnings Conference Call. Today, all participants will be in a listen-only mode. [Operator Instructions] Please note, today???s event is being recorded. At thi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-31573 Medifast, Inc. (Exact name of registrant as specified in its charter) Delaware 13-3714405 (I.R.S. Employer I ...

Medifast, Inc. (NYSE:MED) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET Company Participants Reed Anderson - ICR Investor Relations Dan Chard - Chairman and Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Chris Neamonitis - Jefferies Doug Lane - Lane Research Operator Good afternoon and welcome to the Medifast Second Quarter 2021 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-31573 Medifast, Inc. (Exact name of registrant as specified in its charter) Delaware 13-3714405 (I.R.S. Employer Identi ...

Medifast, Inc. (NYSE:MED) Q1 2021 Results Conference Call May 4, 2021 4:30 PM ET Company Participants Reed Anderson - IR Dan Chard - Chairman and CEO Jim Maloney - CFO Conference Call Participants Doug Lane - Lane Research Linda Bolton Weiser - D.A. Davidson Sebastian Barbero - Jefferies Operator Good day, and welcome to the Medifast First Quarter 2021 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today???s presentation, there will be an opportunity ...

Table of Contents OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-31573 Medifast, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 (Exact name of registrant as specified in its charter) Delaware 13-3714405 (I.R.S. Employer Ident ...

Medifast, Inc. (NYSE:MED) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants Reed Anderson - Investor Relations Dan Chard - Chairman and Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Doug Lane - Lane Research Sebastian Barbero - Jefferies Kara Anderson - B. Riley FBR Operator Good day, and welcome to the Medifast Fourth Quarter and Full Year 2020 Earnings Conference Call. All participants will be a listen-only mode. [Operator Instr ...